Can a nasal air device calm Asthma's hidden nerve stress?

NCT ID NCT05704101

Completed Knowledge-focused Sponsor: RWTH Aachen University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed study looked at how nasal high-flow therapy (NHFT) affects breathing and the nervous system in 30 adults with asthma. Researchers measured nerve activity and heart rate to see if NHFT could reduce overactive stress signals. The goal was to gather knowledge, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nasal high-flow therapy
What this could lead to: If successful, this could help researchers understand whether nasal high-flow therapy might improve breathing and reduce stress on the nervous system in people with asthma.
What could go wrong: This is a small, early-stage study focused on measuring body signals, not on treating asthma. The results may not lead to any new treatment or apply to all asthma patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

University Hospital RWTH Aachen-Department of Pneumology and Intensive Care

Aachen, North Rhine-Westphalia, 52074, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.